08.09.23
Lipovantage, a liposomal technology manufactured by Specnova, had a superior performance to competing liposomal technology in a head-to-head comparison study on vitamin C, according to the company.
Liposomes are minute phospholipid molecules which can enclose a water droplet, and hence enclose water-soluble nutrients and active ingredients in nutraceutical and pharmaceutical applications for the purpose of improving absorption.
In a head-to-head comparison with a leading liposomal brand used in the nutraceuticals marketplace, Lipovantage delivered 405 mg of vitamin C to small intestines, while the competitor’s technology delivered 290 mg, representing a 30% superior delivery, Specnova reported.
In a separate randomized, double-blind, placebo-controlled human clinical study, vitamin C encapsulated in Lipovantage was 27% more bioavailable than non-liposomal vitamin C, and white blood cells received 20% more vitamin C when it was encapsulated in Lipovantage. The vitamin C also stayed in white blood cells for a significantly longer duration when it was encapsulated with Lipovantage, according to Specnova.
“Vitamin C is unstable in the 6.8 pH of the small intestine, but Lipovantage’s proprietary technology protects and stabilizes the Vitamin C,” said Sebastian Balcombe, founder and CEO. “The result is that more Vitamin C is available to be absorbed by the body—and consumers are positioned to receive supercharged benefits through the most sophisticated nutrient delivery system available today. As an alternative to mega-dosing, which is common with vitamin C, Lipovantage liposomes increase bioavailability so the body can absorb the active ingredient more thoroughly and efficiently. This also prevents side effects caused by vitamin C mega-doses, like upset stomach, nausea, and diarrhea.”
Specnova validates every batch of LipoVantage with its validation process, branded as TruLiposome Validation, which tests for multiple criteria required for efficacy. The company’s proprietary DualMatrix Shield Technology can further increase stability in the body, bioavailability, and shelf life.
Liposomes are minute phospholipid molecules which can enclose a water droplet, and hence enclose water-soluble nutrients and active ingredients in nutraceutical and pharmaceutical applications for the purpose of improving absorption.
In a head-to-head comparison with a leading liposomal brand used in the nutraceuticals marketplace, Lipovantage delivered 405 mg of vitamin C to small intestines, while the competitor’s technology delivered 290 mg, representing a 30% superior delivery, Specnova reported.
In a separate randomized, double-blind, placebo-controlled human clinical study, vitamin C encapsulated in Lipovantage was 27% more bioavailable than non-liposomal vitamin C, and white blood cells received 20% more vitamin C when it was encapsulated in Lipovantage. The vitamin C also stayed in white blood cells for a significantly longer duration when it was encapsulated with Lipovantage, according to Specnova.
“Vitamin C is unstable in the 6.8 pH of the small intestine, but Lipovantage’s proprietary technology protects and stabilizes the Vitamin C,” said Sebastian Balcombe, founder and CEO. “The result is that more Vitamin C is available to be absorbed by the body—and consumers are positioned to receive supercharged benefits through the most sophisticated nutrient delivery system available today. As an alternative to mega-dosing, which is common with vitamin C, Lipovantage liposomes increase bioavailability so the body can absorb the active ingredient more thoroughly and efficiently. This also prevents side effects caused by vitamin C mega-doses, like upset stomach, nausea, and diarrhea.”
Specnova validates every batch of LipoVantage with its validation process, branded as TruLiposome Validation, which tests for multiple criteria required for efficacy. The company’s proprietary DualMatrix Shield Technology can further increase stability in the body, bioavailability, and shelf life.
